• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. VISIFLEX; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. VISIFLEX; BIFURCATED STENT GRAFT Back to Search Results
Model Number 28-16-155BL - US SUREPASS_H
Device Problems Collapse (1099); Detachment Of Device Component (1104); Leak/Splash (1354)
Patient Problems Aneurysm (1708); Failure of Implant (1924)
Event Date 04/05/2018
Event Type  Injury  
Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
Endologix was made aware of a patient with a bifurcated device collapse with an endoleak and aaa expansion from a follow up ct scan.The rep spoke to the patient's current physician, dr.(b)(6) at (b)(6) and noted that a secondary procedure will be needed.Patient is scheduled (tentatively) for a re-intervention to be performed on (b)(6).Patient had a prior endologix afx/strata graft implanted at (b)(6) hospital by dr (b)(6) some years back (2008).
 
Manufacturer Narrative
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned as the device remains implanted therefore no evaluation was completed.At the completion of the clinical assessment, clinical was able to find substantial evidence to support the following finding of the main body stent collapse and sac growth.Clinical was able to find substantial evidence to support the following additional findings of type iiia endoleak with complete component separation.Due to the lack of relivent medical records, clinical was unable to confirm the reported event of urgent presentation, treated with non- endologix device and fem-fem bypass graft during the secondary endovascular procedure.Device, user, procedure or anatomy relatedness and procedure related harms of this complaint could not be determined based on the information shared with endologix to review.The final patient status was reported to be stable.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISIFLEX
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
MDR Report Key7468775
MDR Text Key106758055
Report Number2031527-2018-00386
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 04/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date10/30/2009
Device Model Number28-16-155BL - US SUREPASS_H
Device Catalogue NumberF00193
Device Lot NumberW06-1349R-009
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/05/2018
Initial Date FDA Received04/27/2018
Supplement Dates Manufacturer Received04/05/2018
Supplement Dates FDA Received06/29/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CUFF STENT GRAFT, LOT W07-2443-016; CUFF STENT GRAFT, LOT W07-2443-016
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-